Adjuvant chemotherapy for stage III colon cancer: relative dose intensity and survival among veterans

BACKGROUND: Given the paucity of information on dose intensity, the objective of this study is to describe the use of adjuvant chemotherapy for stage III colon cancer, focusing on relative dose intensity (RDI), overall survival (OS) and disease-free survival (DFS). METHODS: Retrospective cohort of 3...

Descripción completa

Detalles Bibliográficos
Autores principales: Aspinall, Sherrie L, Good, Chester B, Zhao, Xinhua, Cunningham, Francesca E, Heron, Bernadette B, Geraci, Mark, Passero, Vida, Stone, Roslyn A, Smith, Kenneth J, Rogers, Renee, Shields, Jenna, Sartore, Megan, Boyle, D Patrick, Giberti, Sherry, Szymanski, John, Smith, Doug, Ha, Allen, Sessions, Jolynn, Depcinski, Shawn, Fishco, Shane, Molina, Irvin, Lepir, Tanja, Jean, Carmela, Cruz-Diaz, Lymaris, Motta, Jessica, Calderon-Vargas, Rebeca, Maland, Janelle, Keefe, Sean, Tague, Marshall, Leone, Alice, Glovack, Brian, Kaplan, Blair, Cosgriff, Sean, Kaster, Lindsay, Tonnu-Mihara, Ivy, Nguyen, Kimmai, Carmichael, Jenna, Clifford, Linda, Lu, Kan, Chatta, Gurkamal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4352567/
https://www.ncbi.nlm.nih.gov/pubmed/25884851
http://dx.doi.org/10.1186/s12885-015-1038-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4352567/
https://www.ncbi.nlm.nih.gov/pubmed/25884851
http://dx.doi.org/10.1186/s12885-015-1038-y

Ejemplares similares